BioSpace News Archive

Drug Development

GW’s Cannabidiol Epidiolex Hits in Phase III Trial for Rare Form of Epilepsy

GW Pharmaceuticals anticipates filing a supplemental New Drug Application with the FDA for the new indication later this year.

May 7, 2019
·
2 min read
·
Alex Keown
Drug Development

AstraZeneca Halts Phase III CLL Trial Early After Primary Endpoints Are Met

Full data will be shared at a later conference, but the study marked the first time a BTK inhibitor showed benefit as a monotherapy in CLL.

May 7, 2019
·
2 min read
·
Alex Keown
Deals

BioSpace’s List of May 2019 Life Science IPOs

A summary of IPOs from companies in the biotech and pharma world since May 1, 2019.

May 7, 2019
·
1 min read
·
Editorial Staff
Drug Development

Playing Catch-up, Genentech’s Oral Drug for SMA Shows Promise in Clinical Trials

Genentech, a Roche company, presented data from its FIREFISH clinical trial of risdiplam in Type 1 spinal muscular atrophy (SMA) at the American Academy of Neurology Annual Meeting.

May 7, 2019
·
3 min read
·
Mark Terry
Policy

Will Government Incentives Help Boost Antibiotic Development? Some Pharma Companies Think So

Over and over there are reports about the increasing rise of antibiotic resistant bugs. Even as the number of resistant bacteria increases, the number of companies developing new types of antibiotics is decreasing.

May 7, 2019
·
3 min read
·
Alex Keown
Apogenix to Present at Four Upcoming International Conferences

Apogenix announced that it will present updates on its three most advanced HERA-ligands as well as lead drug candidate asunercept at four upcoming international conferences.

May 7, 2019
·
4 min read
Drug Development

PDC*line Pharma obtains authorization to launch phase I/II trial of its cancer vaccine (PDC*lung01) in non-small cell lung cancer

PDC*line is a potent, scalable and versatile professional antigen-presenting T-cell with great potential for treating a range of cancers

May 7, 2019
·
5 min read
Deals

Ultragenyx Reports First Quarter 2019 Financial Results and Corporate Update

Strong Crysvita® (burosumab) Launch Continues with Approximately 730 Patients on Reimbursed Commercial Therapy in the United States

May 7, 2019
·
8 min read
Job Trends

Prospective Data Demonstrates Effective Pain Relief and Improved Function Using Medtronic’s Evolve(SM) Workflow with Spinal Cord Stimulation

To Assess the Potential of Non-Opioid Treatment Options for Chronic Pain, Study Evaluates Pain Relief, Patient Function and Satisfaction

May 7, 2019
·
7 min read
Recipharm launches Recipharm Inhalation SolutionsTM as its end-to-end offering for inhalation products

Recipharm, the contract development and manufacturing organisation, has launched its end-to-end inhalation offering to provide customers with a fully integrated service from early stage development through to commercial manufacturing.

May 7, 2019
·
3 min read